Enlivex to commence Phase IIb trial of cell therapy for Covid-19 ARDS
The trial will assess the safety and efficacy of Allocetra given along with the standard of care in a total…

The trial will assess the safety and efficacy of Allocetra given along with the standard of care in a total…
The VLP vaccine addresses three surface proteins of SARS CoV-2, which could allow its efficacy against viral variants.
The data from the Phase III trial is anticipated to allow future trials of the therapeutic for treating Covid-19 patients.
The primary goals of the trial are the drug’s safety and ability to address behavioural disturbances in Alzheimer's patients.
The trial’s primary endpoint is the proportion of participants not requiring oxygen support by day 14.
Chemomab Therapeutics has enrolled the first subject in its Phase IIa study of humanised monoclonal antibody CM-101 in Non-Alcoholic Steatohepatitis…
Todos Medical has started a Phase II clinical trial to evaluate the safety and efficacy of its antiviral NLC-V-01 (Tollovir),…
Kamada has reported top-line results from its Phase I/II clinical trial of anti-SARS-CoV-2 plasma-derived hyperimmune globulin (IgG) treating hospitalised Covid-19…